The discovery of fluazaindolizine: A new product for the control of plant parasitic nematodes
作者:George P. Lahm、Johan Desaeger、Ben K. Smith、Thomas F. Pahutski、Michel A. Rivera、Tony Meloro、Roman Kucharczyk、Renee M. Lett、Anne Daly、Brenton T. Smith、Daniel Cordova、Tim Thoden、John A. Wiles
DOI:10.1016/j.bmcl.2017.02.029
日期:2017.4
Fluazaindolizine is a new highly effective and selective product for the control of plant parasitic nematodes. Specificity for nematodes coupled with absence of activity against the target sites of commercial nematicides suggests that fluazaindolizine has a novel mode of action. The discovery, structure-activity development and biological properties for this new class of nematicides are presented.
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
申请人:Qiao X. Jennifer
公开号:US20070129361A1
公开(公告)日:2007-06-07
The present application describes lactam-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof of Formula I:
P-M-M
1
I
or pharmaceutically acceptable salt forms thereof, wherein M is a linear core. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
LACTAM CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS
申请人:Qiao X Jennifer
公开号:US20070135428A1
公开(公告)日:2007-06-14
The present application describes lactam-containing cyclic diamines and derivatives thereof of Formula I:
P
4
-M-M
4
I
or pharmaceutically acceptable salt forms thereof, wherein M is a non-aromatic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.